Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gamida Cell Ltd. - Ordinary Shares (NQ: GMDA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gamida Cell Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to dive into all of the biggest pre-market stock movers that traders will want to keep an eye on Friday morning! 
Via InvestorPlace
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly... 
Via Benzinga
Exposures Glyphosate
Why Gamida Cell Shares Are Falling Today
Gamida Cell shares plummet as the company enters a restructuring agreement with Highbridge Capital Management, aiming to secure long-term financial stability. 
Via Benzinga
Gamida Cell Earnings Preview
Via Benzinga
Expert Ratings for Gamida Cell
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter. 
Via Benzinga
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors 
From Aquestive Therapeutics, Inc.
Via GlobeNewswire
US Stocks Flat; Initial Jobless Claims Fall To 210,000
U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday. Following the market opening Thursday, the Dow traded down 0.02% to 39,753.17 while the NASDAQ fell... 
Via Benzinga
Topics Stocks
Exposures US Equities
Recap: Gamida Cell Q3 Earnings
Via Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of... 
Via Benzinga
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday as we check out all of the biggest stories moving shares this morning! 
Via InvestorPlace
Gold Moves Higher; Velo3D Shares Plummet
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index gaining over 300 points on Wednesday. The Dow traded up 0.78% to 39,589.55 while the NASDAQ fell 0.02% to 16,312.74.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Edges Lower; PaySign Shares Spike Higher
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 200 points on Wednesday. The Dow traded up 0.56% to 39,502.25 while the NASDAQ fell 0.08% to 16,302.03. The S&P... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Trump Media (DJT) Stock Jumps 18% in Second Trading Day
Trump Media & Technology stock is on the rise Wednesday as shares of DJT continue to rally for the second day after going public. 
Via InvestorPlace
Topics Government
Exposures Political
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates. 
Via Benzinga
GMDA Stock Earnings: Gamida Cell Beats EPS, Beats Revenue for Q4 2023
GMDA stock results show that Gamida Cell beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Hedgeye Warns That Reddit (RDDT) Stock Will Fall 50%
Reddit stock is a hot topic among traders on Wednesday after one analyst warns that RDDT could give up 50% of its gains. 
Via InvestorPlace
Why Is Gamida Cell (GMDA) Stock Down 82% Today?
Gamida Cell stock is falling on Wednesday with heavy trading of GMDA shares after the company announced plans to go private. 
Via InvestorPlace
Dow Jumps Over 200 Points; UniFirst Posts Downbeat Earnings
U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.58% to 39,511.62 while the NASDAQ rose 0.60%... 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga
Small-Caps Grossly Underperform Broader Market Amid This Red Flag: 5 Stocks On The Scanner
Small-cap stocks have not taken off significantly this year despite the broader market rebound, primarily due to their increasing debt burden, a report says. 
Via Benzinga
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. 
Via Benzinga
Gamida Cell's Blood Cancer Candidate Shows Encouraging Anti-Tumor Activity In Heavily Pretreated Patients
Gamida Cell Ltd (NASDAQ: GMDA) released new early data in 10 patients with CD20-positive non-Hodgkin lymphoma enrolled in the first three cohorts in an ongoing Phase 1 study of natural killer (NK)  
Via Benzinga
Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Issues Update on Israel Operations
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
From Gamida Cell Ltd.
Via Business Wire
First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv)
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference
From Gamida Cell Ltd.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.